J&J Anticipates Up To 14 NME Filings In 2006/2007
This article was originally published in The Pink Sheet Daily
Executive Summary
The company’s protease inhibitor TMC 114, which has a June 23 user fee date, will carry the brand name Prezista.
You may also be interested in...
J&J Could File “New Gold Standard” In Anti-TNF Therapy By Late 2007
CNTO 148 is in Phase III for RA, ankylosing spondylitis and psoriatic arthritis.
J&J Could File “New Gold Standard” In Anti-TNF Therapy By Late 2007
CNTO 148 is in Phase III for RA, ankylosing spondylitis and psoriatic arthritis.
J&J Pharma Sales Force Reduced As Part Of Efficiencies Program
Firm says it has implemented a "modest" sales force reduction.